
Global Digital Biomarker Market Analysis, 2020
By Type (Clinical Trials, Clinical Settings), By Data Collection (Wearables, Biosensors, Mobile Apps, Devices & Platforms, Desktop Based Software), By Application (Sleep & Movement..., Cardiovascular, Pain Management, Mood & Behavior, Neurodegenerative Disorders, Respiratory Ailment), By End-User (Biopharma Firms, Payers, Providers), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, Italy, France, Spain, Russia, Scandinavia, The Netherland, China, Japan, Singapore, South Korea, India, Australia, GCC) Read more
- Healthcare
- Jun 2020
- 187
- PDF, Excel, PPT
Digital Biomarkers refer to the data which collected about health for earlier detection and prevention of diseases. The Global Digital Biomarker Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Digital Biomarker market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report “Global Digital Biomarker Market Analysis, 2020”, the Global Digital Biomarker market is anticipated to grow at a CAGR of around 42 % during 2020-25. Based on end user, Biopharma segment accounted for the highest portion in the Global Digital Biomarker market share in 2019. However, it is projected that the health insurance payers’ segment would foresee growth at the highest rate in the forecast period on an account of rising usage of the digital biomarkers by payer companies to efficiently develop customized care plans.
Pain Management Accounted for a Significant Market Share
Based on application, pain management held the considerable market share in the Global Digital Biomarker market in 2019 on an account of technological advancements in healthcare and adoption of 4th generation technologies such as AR/VR solutions which are used for the detection and treatment of chronic pain. However, the cardiovascular segment is also projected to proliferate in the forecast period due to rise in cardiovascular diseases (CVDs) worldwide as stated in the MarkNtel Advisors’ research report “Global Digital Biomarker Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Digital Biomarker market include Bayer AG, AliveCor Inc, Altoida Inc, Akili Interactive Labs, Actigraph LLC, Biogen Inc, Eli Lily, Evidation Health, GSK PLC, Fitbit Inc, Human API, Happify Health, IXICO PLC, Neurotrack Technology, Novartis, Pfizer, F. Hoffman- La Roche, Takeda Pharmaceuticals, Amgen Inc, Verily Life Sciences etc. To gain competitive advantage over the other market players, these companies are continuously raising funds to introduce new technologies in the healthcare sector.
Key Questions Answered in the Market Research Report
- What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Digital Biomarker Market?
- What is the region wise industry size, growth drivers and challenges key market trends?
- What are the key innovations, technology upgrades, opportunities, regulations in the Global Digital Biomarker Market?
- Who are the key competitors or market players and how they perform in Global Digital Biomarker Market based on competitive benchmarking matrix?
- What are the key results derived from the market surveys conducted during the course of Global Digital Biomarker Market study?
Market Outlook, Segmentation and Statistics
- Global Digital Biomarker Start-Up Ecosystem, 2015-2020
- Global Digital Biomarker Market Overview
- Type of Biomarkers
- Application Areas
- Innovations
- Global Digital Biomarker Market Technology Integration
- Artificial Intelligence
- Immersive Technologies
- Cloud Computing
- Edge Computing
- Blockchain
- Impact of COVD-19 on Global Biomarkers Market
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Type
- Clinical Trials
- Clinical Settings
- By Data Collection
- Wearables
- Biosensors
- Mobile Apps
- Devices & Platforms
- Desktop Based Software
- By Application
- Sleep & Movement
- Cardiovascular
- Pain Management
- Mood & Behavior
- Neurodegenerative Disorders
- Respiratory Ailment
- By Status
- Novel
- Approved
- Original
- By End-User
- Biopharma Firms
- Payers
- Providers
- By Region
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Scandinavia
- The Netherland
- Rest of Europe
- Asia-Pacific
- China
- Australia
- Japan
- India
- Singapore
- South Korea
- Middle East and Africa
- GCC
- North America
- By Type
- By Company
- Revenue Shares
- Strategic Factorial Indexing
- Competitor Placement in MarkNtel Quadrant
- Global Digital Biomarker Market Policies, Regulations, Product Standard
- Global Digital Biomarker Market Hotspots & Opportunities
- Competition Outlook
- Competitor Wise Growth Strategies
- Company Profiles
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Digital Biomarker Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Digital Biomarker Market during 2020-25?
A. The growth rate of Global Digital Biomarker Market during 2020-25 is forecast to be around 42%.
Q. Who are the key competitors or players operating in Global Digital Biomarker Market?
A. Bayer AG, AliveCor Inc, Altoida Inc, Akili Interactive Labs, Actigraph LLC, Biogen Inc, Eli Lily, Evidation Health, GSK PLC, Fitbit Inc, Human API, Happify Health, IXICO PLC, Neurotrack Technology, Novartis, Pfizer, F. Hoffman- La Roche, Takeda Pharmaceuticals, Amgen Inc, Verily Life Sciences etc., are few of the leading players in the Global Digital Biomarker Market.
Q. Which data collection segment would emerge as an opportunity area for players in Global Digital Biomarker Market?
A. Wearables and Mobile app segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Digital Biomarker Market?
A. The APAC grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Digital Biomarker Market.
Frequently Asked Questions
- Introduction
- Product Definition
- Research Process
- Assumptions
- Market Segmentation
- Executive Summary
- Global Digital Biomarker Start-Up Ecosystem, 2015-2020
- Global Digital Biomarker Market Overview
- Type of Biomarkers
- Application Areas
- Innovations
- Global Digital Biomarker Market Technology Integration
- Artificial Intelligence
- Immersive Technologies
- Cloud Computing
- Edge Computing
- Blockchain
- Impact of COVD-19 on Global Biomarkers Market
- Expert Verbatim- Interview Excerpts of Industry Experts
- Global Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- Clinical Trials
- Clinical Settings
- By Data Collection System
- Wearables
- Biosensors
- Mobile Apps
- Devices & Platforms
- Desktop Based Software
- By Application
- Sleep & Movement
- Cardiovascular
- Pain Management
- Mood & Behavior
- Neurodegenerative Disorders
- Respiratory Ailment
- By End Users
- Biopharma Firms
- Payers
- Providers
- By Region
- North America
- The US
- Canada
- Mexico
- South America
- Brazil
- Rest of South America
- Europe
- Germany
- The UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Scandinavia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Rest of MEA
- North America
- By Type
- Market Size & Analysis
- North America Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- By End Users
- By Country
- The US
- Canada
- Mexico
- North America Digital Biomarkers Growth Drivers & Challenges
- The US Digital Biomarkers Market Outlook, 2015-2025F
- The US Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- The US Digital Biomarker Market Regulations
- Canada Biomarkers Market Outlook, 2015-2025F
- Canada Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Canada Digital Biomarker Market Regulations
- Mexico Digital Biomarkers Market Outlook, 2015-2025F
- The US Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Mexico Digital Biomarker Market Regulations
- Market Size & Analysis
- South America Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- By End Users
- By Country
- Brazil
- Others
- Brazil Digital Biomarkers Market Outlook, 2015-2025F
- Germany Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Market Size & Analysis
- Europe Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- By End Users
- By Country
- Germany
- The UK
- France
- Italy
- Spain
- The Netherlands
- Russia
- Scandinavia
- Rest of Europe
- Europe Digital Biomarkers Growth Drivers & Challenges
- Germany Digital Biomarkers Market Outlook, 2015-2025F
- Germany Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- France Biomarkers Market Outlook, 2015-2025F
- France Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- The UK Digital Biomarkers Market Outlook, 2015-2025F
- Italy Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Spain Digital Biomarkers Market Outlook, 2015-2025F
- Spain Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Italy Digital Biomarkers Market Outlook, 2015-2025F
- Italy Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- The Netherlands Digital Biomarkers Market Outlook, 2015-2025F
- The Netherlands Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Russia Digital Biomarkers Market Outlook, 2015-2025F
- Russia Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Scandinavia Digital Biomarkers Market Outlook, 2015-2025F
- Scandinavia Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Market Size & Analysis
- Asia Pacific Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- By End Users
- By Country
- China
- Japan
- South Korea
- India
- Singapore
- Australia
- Rest of APAC
- Asia Pacific Digital Biomarkers Growth Drivers & Challenges
- China Digital Biomarkers Market Outlook, 2015-2025F
- China Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Japan Digital Biomarkers Market Outlook, 2015-2025F
- Japan Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- South Korea Digital Biomarkers Market Outlook, 2015-2025F
- South Korea Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- India Digital Biomarkers Market Outlook, 2015-2025F
- India Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Singapore Digital Biomarkers Market Outlook, 2015-2025F
- Singapore Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Australia Digital Biomarkers Market Outlook, 2015-2025F
- Australia Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Market Size & Analysis
- Middle East & Africa Digital Biomarkers Market Outlook, 2015-2025F
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- By End Users
- By Country
- GCC
- Others (Mention names)
- Middle East & Africa Digital Biomarkers Growth Drivers & Challenges
- GCC Digital Biomarkers Market Outlook, 2015-2025F
- GCC Digital Health Ecosystem
- Market Size & Analysis
- By Revenues
- Market Share & Analysis
- By Type
- By Data Collection System
- By Application
- Market Size & Analysis
- Global Digital Biomarkers Market Dynamics
- Drivers
- Challenges
- Impact Analysis
- Global Digital Biomarkers Market Trends & Insights
- Global Digital Biomarkers Market Regulations, Product Standards
- Global Digital Biomarkers Market Case Studies
- Parkinson
- Alzheimer
- Cardiovascular
- Others
- Global Digital Biomarkers Market Intellectual Property Rights Analysis
- Global Digital Biomarkers Market Hotspots & Opportunities
- Competition Outlook
- Competitor Wise Growth Strategies
- Product Portfolio
- Financial Information
- Brand Specialization
- Target Markets
- Research & Development
- Strategic Alliances & Initiatives
- Company Profiles
- Bayer AG
- AliveCor Inc
- Altoida Inc
- Akili Interactive Labs
- Actigraph LLC
- Biogen Inc
- Eli Lily
- Evidation Health
- GSK PLC
- Fitbit Inc
- Human API
- Happify Health
- IXICO PLC
- Neurotrack Technology
- Novartis
- Pfizer
- F. Hoffman- La Roche
- Takeda Pharmaceuticals
- Amgen Inc
- Verily Life Sciences
- Competitor Wise Growth Strategies
- Disclaimer
